Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mifepristone

EU orphan designation number: EU/3/11/925   
Active ingredient: Mifepristone
Indication: Treatment of hypercortisolism (Cushing's syndrome) of endogenous origin
Sponsor: Dr Ulrich Granzer
Mauerkircherstrasse 105, 81925 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2011 Orphan designation EMA/OD/073/11 (2011)7902 of 27/10/2011
27/12/2012 Transfer of orphan designation EMA/OD/073/11/T/01 (2012)9812 of 17/12/2012
18/10/2013 Transfer of orphan designation EMA/OD/073/11/T/02 (2013)6967 of 16/10/2013
12/08/2015 Transfer of orphan designation EMA/OD/073/11/T/03 (2015)5785 of 10/08/2015